Research & Data

Ovarian PRP Rejuvenation: What the Evidence Actually Shows in 2026

Platelet-rich plasma injected into ovaries to 'restore' fertility — the theory, the data, and what patients need to know before spending money.

July 2026 · 8 min read

If you've been researching IVF with diminished ovarian reserve, you've probably encountered ads for "ovarian rejuvenation" — a procedure where platelet-rich plasma (PRP) is injected directly into the ovaries with the claim that it can reactivate dormant follicles, raise AMH levels, and restore fertility. The promises are extraordinary. The evidence isn't.

This article examines what we actually know about ovarian PRP in 2026 — the theoretical basis, the published data, who's selling it, and what patients considering it should understand before spending money.

What Ovarian PRP Claims to Do

The theoretical mechanism: PRP contains growth factors (PDGF, TGF-β, VEGF, EGF) that could — hypothetically — stimulate inactive primordial follicles in the ovarian cortex, promoting their maturation and increasing the pool of retrievable eggs. Some proponents claim PRP can raise AMH levels, restore menstrual cycles in perimenopausal women, and even reverse premature ovarian insufficiency (POI).

⚠️ Evidence Status: Experimental
As of 2026, ovarian PRP rejuvenation has NOT been validated by large randomized controlled trials. The published data consists primarily of small case series, pilot studies, and retrospective reports — many from the same groups that sell the procedure. No major reproductive medicine society (ASRM, ESHRE, REDLARA) endorses ovarian PRP as a standard treatment.

What the Published Data Actually Shows

Study TypeWhat Was FoundLimitations
Case series (10–30 patients)Some patients showed AMH increases and/or follicular growth post-injectionNo control group; placebo effect and natural variation not excluded
Pilot RCTs (small)Mixed results; some showed modest AMH increases vs shamSmall sample sizes (n < 50); short follow-up; high risk of bias
Retrospective reviewsSelected patients who improved after PRP reported as successesPublication bias; failures not reported; selection bias
Large-scale RCTsNot yet completed as of mid-2026This is the data gap that matters most

The honest summary: some patients do show AMH increases and follicular growth after ovarian PRP. Whether this translates to more eggs retrieved, more embryos, and more live births — the only outcomes that matter — remains unproven. Some studies report pregnancies after PRP, but without proper controls, we can't distinguish PRP effect from natural conception that would have occurred regardless.

Who's Selling It and What to Watch For

Ovarian PRP is offered by fertility clinics worldwide, including in Colombia, at prices ranging from $1,500 to $5,000 per injection. Some offer it as a standalone procedure; others bundle it with IVF cycles. The marketing language is telling:

Red Flag Language

Honest Language

Key Takeaway
Ovarian PRP is an experimental procedure with intriguing theory and weak evidence. It is not a proven alternative to donor eggs for patients with severely diminished ovarian reserve. If a Colombian or any clinic recommends it, they should be transparent about the evidence level and not present it as a validated treatment. Consider it only if you fully understand the experimental status and the cost ($1,500–$5,000 in Colombia) won't compromise your ability to pursue proven treatment paths.

Questions About Ovarian Rejuvenation?

We'll connect you with Colombian fertility specialists who can give you an honest assessment of whether PRP or other approaches make sense for your specific situation.

Chat on WhatsApp